← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AFAXYS · Approved 2022-06-09

Drug application

FDA Application #
ANDA215132
Application type
Abbreviated New Drug Application (Generic)
Brand name
LIDOCAINE HYDROCHLORIDE
Generic name
LIDOCAINE HYDROCHLORIDE
Active ingredients
LIDOCAINE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
AFAXYS
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
First approval
2022-06-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown